Drug makers have agreed with the US government to spend $80 billion over the next ten years in a bid …
Pharmaceutical group Helsinn is planning to expand its manufacturing capabilities with a new round of investment at a production facility …
How did you find your way into your current role?I have worked for several years in the Canadian pharmaceutical industry …
Astellas has struck a deal with Californian company NeurogesX to market in Europe a treatment for pain linked to peripheral …
The stable market for parallel imports in recent years suggests pharma quotas on wholesalers have not dampened the trade, according to a parallel distributor …
Pharmafocus presents a round-up of developments in manufacturing, including facility updates from Genzyme, Norwich Pharma and Kemwell/Boehringer Ingelheim, progress with …
Merck Serono is to begin a global phase III study for its therapeutic cancer vaccine Stimuvax in patients with advanced, …
Switzerland-based contract research organisation PFC Pharma Focus has set up an Indian subsidiary with the help of Excel Life Sciences, …
Some developments at NICE, now celebrating its 10th birthday, may have passed you by. They have moved beyond their technology …
The NHS is under fire from MPs for failing to improve productivity despite a pay bill which has risen 5.2% …
Bristol-Myers Squibb and AstraZeneca have joined forces with Diabetes UK to launch a national patient survey on the effects of …
Sanofi-Aventis is to set aside 100 million flu vaccine doses for the developing world in order to fight the emerging …
Boehringer Ingelheim and Pennsylvania-based Vitae Pharmaceuticals have signed a global agreement to develop novel treatments for Alzheimer's. The disease currently …
Key highlights of the recent American Society of Clinical Oncology's 45th Annual Meeting in Florida saw current blockbusters advance standard …
The UK's health service is heading for a severe financial shortfall and will have to consider limiting spending, including on …

GlaxoSmithKline will increase its reach into emerging markets with a new deal to co-market generics with Dr. Reddy’s.The Indian company …
Plavix is to face competition from six generics in Europe, potentially decimating sales of Sanofi-Aventis' brand in the region. Plavix …
The European Commission has opted not to press ahead with developing a Directive on Good Manufacturing Practices for ‘certain’ pharmaceutical …
A new PR body has been launched and tasked with shedding some light on how to promote healthcare clients online …